IL17A and chronic obstructive pulmonary disease: IL-17 expression levels in bronchial mucosa are positively correlated with disease severity; whereas this factor enhances antimicrobial defense during acute infections, its dysregulation in COPD patients contributes to immune deficiency and increased infection risk.